anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 19.06.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 19.06.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 16.06.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.06.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 12.06.17 | Novo Nordisk buy | UBS AG | |
| 26.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 24.05.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 12.05.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 04.05.17 | Novo Nordisk buy | UBS AG | |
| 04.05.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 04.05.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 04.05.17 | Novo Nordisk Reduce | HSBC | |
| 03.05.17 | Novo Nordisk Hold | S&P Capital IQ | |
| 03.05.17 | Novo Nordisk buy | UBS AG | |
| 28.04.17 | Novo Nordisk buy | UBS AG | |
| 11.04.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 05.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.04.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 23.03.17 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 09.03.17 | Novo Nordisk buy | UBS AG | |
| 08.03.17 | Novo Nordisk Underweight | Barclays Capital | |
| 06.03.17 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.03.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 28.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 21.02.17 | Novo Nordisk Hold | Kepler Cheuvreux | |
| 16.02.17 | Novo Nordisk buy | UBS AG | |
| 09.02.17 | Novo Nordisk Hold | Commerzbank AG | |
| 06.02.17 | Novo Nordisk verkaufen | JP Morgan Chase & Co. | |
| 06.02.17 | Novo Nordisk Hold | HSBC | |
| 03.02.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.02.17 | Novo Nordisk buy | UBS AG | |
| 03.02.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 03.02.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 03.02.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 30.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 27.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 24.01.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.01.17 | Novo Nordisk Hold | Commerzbank AG | |
| 23.01.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. |